Cardiovascular Risk in South America Compared to Other Countries
- 4 Downloads
Purpose of Review
The goal is to discuss the prevalence of cardiovascular risk in South America compared to other countries.
The results highlight the importance of evidence-based approaches to promote the reduction of the prevalence of cardiovascular risk factors in a global context. Indicating the need for policies that promote cardiac health in the global sphere.
Future efforts to generate global of risk factors for cardiovascular disease should be implemented. As well as prevention and treatment measures aimed at decreasing cardiovascular outcomes.
KeywordsHypertension Cardiovascular risk factors Lipids Metabolic syndrome Cardiovascular disease
Acute myocardial infarction
Coronary artery disease
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no conflicts of interest.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 7.•• Yusuf S, Hawken S, Ounpuu S, INTERHEART Study Investigators, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364:937–52. Association of cardiovascular risk factors with acute myocardial infarction. CrossRefPubMedGoogle Scholar
- 8.•• Lanas F, Avezum A, Bautista LE, INTERHEART Investigators in Latin America, et al. Risk factors for acute myocardial infarction in Latin America: the INTERHEART Latin American study. Circulation. 2007;115:1067–74. Association of cardiovascular risk factors with acute myocardial infarction. CrossRefPubMedGoogle Scholar
- 9.Ciruzzi M, Schargrodsky H, Pramparo P, Rivas Estany E, Rodriguez Naude L, de la Noval Garcia R, et al. Attributable risks for acute myocardial infarction in four countries of Latin America. Medicina (B Aires). 2003;63:697–703.Google Scholar
- 20.Borghi C, Rodriguez-Artalejo F, De Backer G, Dallongeville J, Medina J, Guallar E, et al. The association between blood pressure and lipid levels in Europe: European Study on Cardiovascular Risk Prevention and Management in Usual Daily Practice. J Hypertens. 2016;34(11):2155–63.CrossRefPubMedGoogle Scholar
- 24.Cipriani P, Ciccia F, Guggino G, et al. Cardiovascular disease in primary Sjögren’s syndrome. Rev Recent Clin Trials. 201:15. https://doi.org/10.2174/1574887113666180315130336.
- 25.Caso F, Tasso M, Ambrosino P, et al. Cardiovascular risk markers and major adverse cardiovascular events in psoriatic arthritis patients. Rev Recent Clin Trials. 2018;13 https://doi.org/10.2174/1574887113666180314105511.
- 26.Kolliker Frers RA, Cosentino V, et al. Immune-mediated inflammation promotes subclinical atherosclerosis in recent-onset psoriatic arthritis patients without conventional cardiovascular risk factors. Front Immunol. 2018;9:139. https://doi.org/10.3389/fimmu.2018.00139.CrossRefPubMedPubMedCentralGoogle Scholar